FDA Issues A Serious Warning For An Abbott Drug
Make a commentBy Ed Silverman // June 30th, 2011 // 4:19 pm
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « May | Jul » | |||||
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | ||
• Pharma Blog » 2011
Pharmalot June, 2011 Archive
Minnesota Pols Slam FDA For Device Approvals
3 CommentsBy Ed Silverman // June 30th, 2011 // 11:39 am
What Docs Think Of Pharma & Where They Get Info
16 CommentsBy Ed Silverman // June 30th, 2011 // 8:56 am
Avastin & FDA Were Both On Trial: Dan Explains
11 CommentsBy Ed Silverman // June 30th, 2011 // 7:45 am
Congress Widens Probe Into The Heparin Scandal
3 CommentsBy Ed Silverman // June 30th, 2011 // 6:55 am
FDA Panel Rejects Avastin Breast Cancer Indication
1 CommentBy Ed Silverman // June 29th, 2011 // 3:07 pm
Maine Data Mining Law Gets A Judicial Review
7 CommentsBy Ed Silverman // June 29th, 2011 // 11:38 am
Pfizer Distribution Is Hurting Patients Down Under
6 CommentsBy Ed Silverman // June 29th, 2011 // 10:40 am
Why The ‘Dog Ate My Homework’ Amendment Benefits A Drugmaker And A Big Law Firm
3 CommentsBy Ed Silverman // June 29th, 2011 // 9:35 am